Biocon Limited informed shareholders about tax deduction at source on the final dividend for the financial year ended March 31, 2026. The board at its meeting on May 7, 2026 recommended a final dividend of 10%, or Re 0.50 per equity share of face value Rs 5 each.
The dividend is subject to shareholder approval at the 48th Annual General Meeting scheduled for August 6, 2026. The record date for determining eligible shareholders is July 3, 2026.
Under the Income Tax Act, 2025, Biocon will deduct TDS on dividend payments at rates specified for each shareholder category. Resident shareholders with valid PAN face a 10% TDS rate. Those without PAN or with invalid PAN linked to Aadhaar face a 20% rate.
Non-resident shareholders, foreign institutional investors, and foreign portfolio investors are subject to TDS at 20% plus applicable surcharge and cess. Category III alternative investment funds located in International Financial Services Centres attract a 10% rate plus surcharge and cess. Non-resident shareholders claiming benefits under Double Taxation Avoidance Agreements must provide a valid Tax Residency Certificate and file Form 41 electronically.
Shareholders must upload certificates, declarations, and Form 121 through the designated link or send physical documents to KFin Technologies Limited by July 20, 2026. Biocon will not consider forms received after this date.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.